title: Impact of recent black box warnings in the allergy world.
authors.affiliation: Pulmonary and Allergy Associates PA, Cedar Knolls, New Jersey 07927, USA. Nallopp@optonline.net
authors.forename: John
authors.initials: J
authors.lastname: Oppenheimer
authors.forename: Donald
authors.initials: D
authors.lastname: Aaronson
mesh_terms: D000318:Adrenergic beta-Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy / Q000378:metabolism; D065095:Calcineurin Inhibitors; D004348:Drug Labeling; D011307:Drug Prescriptions / Q000706:statistics & numerical data; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy* / Q000378:metabolism; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D007258:Informed Consent / Q000331:legislation & jurisprudence; D010817:Physician-Patient Relations; D011795:Surveys and Questionnaires; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000318:Adrenergic beta-Agonists; D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents